Back to Gene
EPOR gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

EPOR gene

The EPOR gene provides instructions for the erythropoietin receptor, a protein that regulates the production of red blood cells in the bone marrow.

Normal Function

The EPOR gene provides instructions for making a protein called the erythropoietin receptor. Erythropoietin is a hormone that directs the production of new red blood cells (erythrocytes) in the bone marrow. Red blood cells make up about half of total blood volume, and their primary function is to carry oxygen from the lungs to tissues and organs throughout the body. New red blood cells are constantly being produced by the body as worn-out red blood cells are broken down. To trigger the production of red blood cells, erythropoietin attaches (binds) to the erythropoietin receptor. This binding turns on (activates) the receptor, which stimulates several signaling pathways (particularly a cascade of signals known as the JAK/STAT pathway) that lead to the formation and maturation of red blood cells.

Health Conditions Related to Genetic Changes

Familial erythrocytosis

At least 16 mutations in the EPOR gene have been found to cause familial erythrocytosis, an inherited condition characterized by an increased number of red blood cells and an elevated risk of abnormal blood clots. When familial erythrocytosis results from EPOR gene mutations, it is often designated ECYT1.

Most of the identified mutations in the EPOR gene lead to the production of an abnormally short version of the erythropoietin receptor. A few mutations change single protein building blocks (amino acids) in the receptor. All of these mutations alter the structure of the receptor, causing it to remain activated for an abnormally long time after binding to erythropoietin. The overactive receptor signals the production of red blood cells even when no more are needed, which leads to an excess of these cells in the bloodstream.

Other Names for This Gene

  • EPO-R
  • EPOR_HUMAN

Frequently Asked Questions

Familial erythrocytosis (ECYT1) often presents with symptoms related to increased red blood cell volume, such as headache, dizziness, fatigue, shortness of breath, and sometimes a reddish complexion. The most significant complication is an elevated risk of abnormal blood clots, which can lead to serious events like strokes, heart attacks, or deep vein thrombosis.
Management of familial erythrocytosis (ECYT1) focuses on reducing the red blood cell count to a safe level and preventing blood clots. This is often achieved through phlebotomy (therapeutic blood draws) to remove excess red blood cells. In some cases, medications like low-dose aspirin may be prescribed to further reduce the risk of clotting.
Familial erythrocytosis (ECYT1) caused by EPOR gene mutations is inherited in an autosomal dominant pattern. This means if you have the mutation, each of your children has a 50% chance of inheriting the mutation and potentially developing the condition. Genetic counseling can provide more specific risk assessment and family planning information.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab